This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Feb;70(2):523-4; author reply 524-5.

doi: 10.1097/TA.0b013e318206cf03.

Recombinant activated factor VII--"lifesaving or surgeon correcting"?

Jaromir Koci, Tomas Dedek, Eduard Havel, Jan Trlica

PMID: 21307759
DOI: 10.1097/TA.0b013e318206cf03

Comment

Recombinant activated factor VII--"lifesaving or surgeon correcting"?

Jaromir Koci et al. J Trauma. 2011 Feb.

. 2011 Feb;70(2):523-4; author reply 524-5.

doi: 10.1097/TA.0b013e318206cf03.

Authors

Jaromir Koci, Tomas Dedek, Eduard Havel, Jan Trlica

PMID: 21307759
DOI: 10.1097/TA.0b013e318206cf03

No abstract available

PubMed Disclaimer

Comment on

Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, Leppaniemi A, Parr M, Vincent JL, Tortella BJ, Dimsits J, Bouillon B; CONTROL Study Group. Hauser CJ, et al. J Trauma. 2010 Sep;69(3):489-500. doi: 10.1097/TA.0b013e3181edf36e. J Trauma. 2010. PMID: 20838118 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- MedlinePlus Health Information